VCEL Q2 2019 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$26M+37.6% YoY

Gross Profit

$17M65.5% margin

Operating Income

-$20M-77.2% margin

Net Income

-$20M-75.7% margin

EPS (Diluted)

$-0.45

QoQ Revenue Growth

+19.9%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$126M

Total Liabilities

$37M

Stockholders' Equity

$89M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26M	$19M	+37.6%
Gross Profit	$17M	$11M	+51.8%
Operating Income	-$20M	-$4M	-375.7%
Net Income	-$20M	-$5M	-325.5%

Revenue Segments

Product

$26M100%